Suppr超能文献

标记配体置换:扩展基于核磁共振的蛋白质靶点筛选

Labeled Ligand Displacement: Extending NMR-Based Screening of Protein Targets.

作者信息

Swann Steven L, Song Danying, Sun Chaohong, Hajduk Philip J, Petros Andrew M

机构信息

Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064.

出版信息

ACS Med Chem Lett. 2010 Jun 24;1(6):295-9. doi: 10.1021/ml1000849. eCollection 2010 Sep 9.

Abstract

NMR spectroscopy has enjoyed widespread success as a method for screening protein targets, especially in the area of fragment-based drug discovery. However, current methods for NMR-based screening all suffer certain limitations. Two-dimensional methods like "SAR by NMR" require isotopically labeled protein and are limited to proteins less than about 50 kDa. For one-dimensional, ligand-based methods, results can be confounded by nonspecific compound binding, resonance overlap, or the need for a special NMR probe. We present here a ligand-based method that relies on the exchange broadening observed for a (13)C-labeled molecule upon binding to a protein target (labeled ligand displacement). This method can be used to screen both individual compounds and mixtures and is free of the artifacts inherent in other ligand-based methods.

摘要

核磁共振光谱法作为一种筛选蛋白质靶点的方法已取得广泛成功,尤其是在基于片段的药物发现领域。然而,目前基于核磁共振的筛选方法都存在一定局限性。像“核磁共振波谱法的构效关系”这样的二维方法需要同位素标记的蛋白质,并且仅限于分子量小于约50 kDa的蛋白质。对于一维的基于配体的方法,结果可能会因非特异性化合物结合、共振重叠或对特殊核磁共振探针的需求而混淆。我们在此提出一种基于配体的方法,该方法依赖于观察到的(13)C标记分子与蛋白质靶点结合时的交换加宽现象(标记配体置换)。此方法可用于筛选单个化合物和混合物,且不存在其他基于配体的方法所固有的假象。

相似文献

1
Labeled Ligand Displacement: Extending NMR-Based Screening of Protein Targets.
ACS Med Chem Lett. 2010 Jun 24;1(6):295-9. doi: 10.1021/ml1000849. eCollection 2010 Sep 9.
2
NMR-based screening methods for lead discovery.
EXS. 2003(93):183-202. doi: 10.1007/978-3-0348-7997-2_9.
3
Optimizing NMR fragment-based drug screening for membrane protein targets.
J Struct Biol X. 2024 May 25;9:100100. doi: 10.1016/j.yjsbx.2024.100100. eCollection 2024 Jun.
4
Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
Methods Enzymol. 2011;493:469-85. doi: 10.1016/B978-0-12-381274-2.00018-2.
5
Recent applications of isotopic labeling for protein NMR in drug discovery.
Expert Opin Drug Discov. 2013 May;8(5):523-36. doi: 10.1517/17460441.2013.779665. Epub 2013 Mar 12.
6
NMR study to identify a ligand-binding pocket in Ras.
Enzymes. 2013;33 Pt A:15-39. doi: 10.1016/B978-0-12-416749-0.00002-6. Epub 2013 Aug 8.
7
SAR by (Protein-Observed) F NMR.
Acc Chem Res. 2019 Dec 17;52(12):3407-3418. doi: 10.1021/acs.accounts.9b00377. Epub 2019 Nov 13.
8
A Practical Perspective on the Roles of Solution NMR Spectroscopy in Drug Discovery.
Molecules. 2020 Jun 28;25(13):2974. doi: 10.3390/molecules25132974.
9
[NMR screening in fragment-based drug discovery].
Yakugaku Zasshi. 2010 Mar;130(3):325-33. doi: 10.1248/yakushi.130.325.
10
TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery.
Chem Biol. 2005 Feb;12(2):207-16. doi: 10.1016/j.chembiol.2004.12.004.

引用本文的文献

本文引用的文献

1
Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy.
Angew Chem Int Ed Engl. 1999 Jun 14;38(12):1784-1788. doi: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q.
2
Perspectives on NMR in drug discovery: a technique comes of age.
Nat Rev Drug Discov. 2008 Sep;7(9):738-45. doi: 10.1038/nrd2606.
3
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.
Nat Rev Drug Discov. 2008 Feb;7(2):168-81. doi: 10.1038/nrd2467.
4
Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies.
Chem Biol Drug Des. 2007 Jul;70(1):1-12. doi: 10.1111/j.1747-0285.2007.00535.x.
5
Hsp90: a novel target for cancer therapy.
Curr Top Med Chem. 2006;6(11):1205-14. doi: 10.2174/156802606777812068.
8
TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery.
Chem Biol. 2005 Feb;12(2):207-16. doi: 10.1016/j.chembiol.2004.12.004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验